GlassScriptPhysician profile
Emily K Cockrell
NPI 1215554662
$1,210.84
in general payments reported to CMS, 2019-2025
17 companies · $1,189 in 2025
The $1,189 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $22.14 · 2025: $1,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,210.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calliditas Therapeutics US INC. | $281.05 | 2025 | Tarpeyo |
| Shield Therapeutics INC | $277.58 | 2025 | |
| Novo Nordisk INC | $114.99 | 2025 | Ozempic, Rybelsus, Wegovy |
| Travere Therapeutics, INC. | $81.19 | 2025 | |
| Veloxis Pharmaceuticals, INC. | $70.30 | 2025 | Envarsus |
| Pharmacosmos Therapeutics INC. | $66.10 | 2025 | Monoferric |
| Otsuka America Pharmaceutical, INC. | $55.64 | 2025 | Voyxact |
| Mallinckrodt Hospital Products INC. | $53.44 | 2025 | Terlivaz |
| Glaxosmithkline, LLC. | $44.25 | 2025 | Shingrix, Arexvy |
| Alexion Pharmaceuticals, INC. | $24.65 | 2025 | Ultomiris |
| Aurinia Pharma U.S., INC. | $24.63 | 2025 | Lupkynis |
| Ardelyx, INC. | $22.19 | 2025 | Ibsrela |
| Hologic Sales and Service, LLC | $22.14 | 2024 | Thinprep 2000 Processor, Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $22.08 | 2025 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $21.40 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.88 | 2025 | Jardiance |
| Scpharmaceuticals INC. | $14.33 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Cockrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.